Denosumab

Toronto, Canada & Bengaluru, India, April 21, 2026 In a significant advancement for global biosimilars and bone health therapeutics,...

BENGALURU, India & BRIDGEWATER, New Jersey, United States, April 7, 2026 Biocon Limited announced the U.S. commercial launch of...

TORONTO, Ontario, Canada, April 7, 2026 Apotex Inc., a leading global pharmaceutical company, announced that Health Canada has approved...

TEL AVIV, Israel & PARSIPPANY, N.J., USA, March 30, 2026 Teva Pharmaceutical Industries has received U.S. FDA approval for...

Budapest / London, September 29, 2025 Gedeon Richter and Hikma announced that the U.S. Food and Drug Administration (FDA)...

SHANGHAI, China & JERSEY CITY, NJ – September 19, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN)...

BENGALURU, India & BRIDGEWATER, N.J. – September 17, 2025 –Biocon Biologics Ltd. (BBL), a global leader in biosimilars and...